Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia
Clinical trial NCT04331665 · TERMINATED
Trial details
- NCT number
- NCT04331665
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-21
- Primary completion
- 2021-01-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.